Public statement on the increased risk of serious infection and neutropenia in patients treated concurrently with Kineret (anakinra) and Enbrel (etanercept)

News 05/02/2003

List item

Public statement on the increased risk of serious infection and neutropenia in patients treated concurrently with Kineret (anakinra) and Enbrel (etanercept) (PDF/141.63 KB)

First published: 05/02/2003
Last updated: 05/02/2003
EMEA/31631/02

Related content

How useful was this page?

Add your rating

★ ★ ★ ★ ★